Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

3.80
Delayed Data
As of Apr 25
 +0.05 / +1.33%
Today’s Change
2.63
Today|||52-Week Range
6.30
+4.97%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash15.1M22.2M26.9M8.1M
 
 
 
 
 
Short Term Investment Cash181.0K7.1M4.7M-18.8M
 
 
 
 
 
Cash & Short Term Investments39.3M43.0M46.4M42.6M
 
 
 
 
 
 
ReceivablesReceivables0.00--0.000.00--
 
InventoriesInventories0.00--0.000.00--
 
Current AssetsOther Current Assets1.2M1.2M558.0K643.0K
 
 
 
 
 
Current Assets40.5M44.2M47.0M43.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross23.0K------
 
 
Other Assets10.0K0.000.000.00
 
 
Total Assets40.5M44.2M47.0M43.2M
 
 
 
 
 
 
LiabilitiesAccounts Payable953.0K0.002.5M1.9M
 
 
 
 
Short Term Debt9.0M9.3M7.8M3.3M
 
 
 
 
 
Accrued Expenses6.4M6.2M4.7M3.1M
 
 
 
 
 
Other Current Liabilities22.3M16.3M7.1M3.7M
 
 
 
 
 
Other Liabilities34.0M27.9M19.0M10.9M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt9.0M0.000.0011.1M
 
 
 
Other Liabilities0.000.000.00169.0K
 
 
Total Liabilities46.7M30.4M19.6M22.2M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.0016.5M18.8M
 
 
 
Common Equity-6.2M13.8M10.9M2.2M
 
 
 
 
 
Total Shareholder Equity-6.2M13.8M27.4M21.0M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding9.1M11.0M14.4M20.9M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.